Changchun High & New Technology Industry (Group) Inc is currently in a long term downtrend where the price is trading 14.3% below its 200 day moving average.

From a valuation standpoint, the stock is 125.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.7.

Changchun High & New Technology Industry (Group) Inc's total revenue rose by 12.8% to $2B since the same quarter in the previous year.

Its net income has increased by 47.1% to $786M since the same quarter in the previous year.

Finally, its free cash flow fell by 1799.7% to $-979M since the same quarter in the previous year.

Based on the above factors, Changchun High & New Technology Industry (Group) Inc gets an overall score of 2/5.